These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 8599582

  • 1. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C, Ahn YT, Everitt J, Yuan X.
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S, Tokuzen R, Tsuda H, Igawa M, Hino O.
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [Abstract] [Full Text] [Related]

  • 3. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker HJ.
    Cancer Res; 2000 Apr 01; 60(7):1942-8. PubMed ID: 10766184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 Apr 01; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 6. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
    Ashida S, Furihata M, Tanimura M, Sugita O, Yamashita M, Miura T, Moriyama M, Shuin T.
    J Urol; 2003 Jun 01; 169(6):2089-93. PubMed ID: 12771725
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.
    Gallou C, Joly D, Méjean A, Staroz F, Martin N, Tarlet G, Orfanelli MT, Bouvier R, Droz D, Chrétien Y, Maréchal JM, Richard S, Junien C, Béroud C.
    Hum Mutat; 1999 Jun 01; 13(6):464-75. PubMed ID: 10408776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH, Jung CW, Cho YH, Lee J, Lee SH, Kim HY, Park J, Park JO, Kim K, Kim WS, Park YS, Im YH, Kang WK, Park K.
    Oncol Rep; 2005 May 01; 13(5):859-64. PubMed ID: 15809750
    [Abstract] [Full Text] [Related]

  • 12. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
    Ma X, Yang K, Lindblad P, Egevad L, Hemminki K.
    Oncogene; 2001 Aug 30; 20(38):5393-400. PubMed ID: 11536052
    [Abstract] [Full Text] [Related]

  • 13. [Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas].
    Gong K, Zhang Z, Xin D.
    Zhonghua Yi Xue Za Zhi; 2001 Feb 10; 81(3):142-4. PubMed ID: 11798864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells.
    Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S, Kuwano M.
    Int J Cancer; 2003 Jul 20; 105(6):803-10. PubMed ID: 12767066
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
    Knebelmann B, Ananth S, Cohen HT, Sukhatme VP.
    Cancer Res; 1998 Jan 15; 58(2):226-31. PubMed ID: 9443397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ.
    Oncogene; 2000 Dec 14; 19(54):6297-305. PubMed ID: 11175344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.